Sovran Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Sovran Advisors's ALNY Position: Q3 2026 in Review
Sovran Advisors opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 2,173 shares worth $378K. The stake represents 0.03% of the portfolio and ranks #440 among its holdings.
727 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Sovran Advisors held 2,173 shares of Alnylam Pharmaceuticals worth $378K as of Q3 2026.
- Alnylam Pharmaceuticals was a new Sovran Advisors position in Q3 2026.
- Alnylam Pharmaceuticals made up 0.03% of Sovran Advisors's portfolio in Q3 2026, its #440 holding.
- 727 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Sovran Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.